Baader Bank Aktiengesellschaft’s Dr. Reddy's Laboratories RDY Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-52,750	Closed	-$774K	–	472
2024 Q1	$774K	Sell	52,750 -3,670	-7%	-$53.6K	0.06%	181
2023 Q4	$785K	Buy	56,420 +39,020	+224%	+$522K	0.06%	166
2023 Q3	$231K	Buy	17,400 +470	+3%	+$6.36K	0.02%	263
2023 Q2	$212K	Buy	+16,930	New	+$198K	0.01%	318
2022 Q1	–	Sell	-16,250	Closed	-$213K	–	292
2021 Q4	$213K	Buy	+16,250	New	+$205K	0.02%	277

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baader Bank Aktiengesellschaft's RDY Position: Q2 2024 in Review

Baader Bank Aktiengesellschaft sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 52,750 shares — an estimated $774K sold.

Baader Bank Aktiengesellschaft first reported a position in RDY in Q4 2021 and held it in 5 quarters. The position peaked at $785K in Q4 2023. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

Baader Bank Aktiengesellschaft reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 52,750 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $774K.
Baader Bank Aktiengesellschaft first reported a position in Dr. Reddy's Laboratories in Q4 2021 and held it in 5 quarters.
Baader Bank Aktiengesellschaft's Dr. Reddy's Laboratories position peaked at $785K in Q4 2023.
222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2024, filed 17 Jul 2024.